Enimmune Corporation (TPEX:6564)
19.95
+0.15 (0.76%)
At close: Feb 11, 2026
-23.27% (1Y)
| Market Cap | 1.44B -26.0% |
| Revenue (ttm) | 42.23M -16.9% |
| Net Income | -164.74M |
| EPS | -2.22 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,960 |
| Average Volume | 86,894 |
| Open | 19.90 |
| Previous Close | 19.80 |
| Day's Range | 19.35 - 20.00 |
| 52-Week Range | 14.65 - 27.10 |
| Beta | 0.39 |
| RSI | 44.53 |
| Earnings Date | Apr 17, 2026 |